OMERS ADMINISTRATION Corp lessened its holdings in shares of Crocs, Inc. (NASDAQ:CROX - Free Report) by 47.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,500 shares of the textile maker's stock after selling 6,800 shares during the quarter. OMERS ADMINISTRATION Corp's holdings in Crocs were worth $821,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of the stock. UMB Bank n.a. grew its position in shares of Crocs by 46.6% during the 4th quarter. UMB Bank n.a. now owns 447 shares of the textile maker's stock worth $49,000 after purchasing an additional 142 shares in the last quarter. Allianz SE bought a new stake in shares of Crocs during the 4th quarter valued at approximately $53,000. TD Waterhouse Canada Inc. increased its holdings in shares of Crocs by 425.6% during the fourth quarter. TD Waterhouse Canada Inc. now owns 678 shares of the textile maker's stock worth $74,000 after buying an additional 549 shares in the last quarter. Jones Financial Companies Lllp raised its position in Crocs by 38.3% in the fourth quarter. Jones Financial Companies Lllp now owns 744 shares of the textile maker's stock valued at $81,000 after purchasing an additional 206 shares during the last quarter. Finally, Whipplewood Advisors LLC acquired a new stake in Crocs during the 4th quarter worth approximately $96,000. 93.44% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of analysts have weighed in on CROX shares. Needham & Company LLC increased their target price on shares of Crocs from $118.00 to $129.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Robert W. Baird dropped their price objective on shares of Crocs from $180.00 to $150.00 and set an "outperform" rating on the stock in a research note on Monday, February 10th. Piper Sandler decreased their price target on Crocs from $125.00 to $115.00 and set an "overweight" rating for the company in a report on Friday, April 11th. Bank of America upped their target price on Crocs from $144.00 to $153.00 and gave the company a "buy" rating in a report on Friday, February 14th. Finally, KeyCorp lowered their price objective on shares of Crocs from $150.00 to $120.00 and set an "overweight" rating on the stock in a research report on Thursday, January 23rd. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $139.79.
Get Our Latest Stock Analysis on CROX
Crocs Price Performance
Shares of CROX traded down $1.82 during mid-day trading on Tuesday, reaching $112.91. 1,635,333 shares of the stock traded hands, compared to its average volume of 1,501,727. The company has a current ratio of 1.18, a quick ratio of 0.70 and a debt-to-equity ratio of 0.74. Crocs, Inc. has a 1 year low of $86.11 and a 1 year high of $165.32. The company has a market cap of $6.33 billion, a price-to-earnings ratio of 7.06, a price-to-earnings-growth ratio of 1.80 and a beta of 1.46. The firm has a fifty day moving average price of $102.11 and a 200 day moving average price of $103.89.
Crocs (NASDAQ:CROX - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The textile maker reported $3.00 EPS for the quarter, topping analysts' consensus estimates of $2.51 by $0.49. Crocs had a net margin of 23.16% and a return on equity of 46.27%. The business had revenue of $937.33 million during the quarter, compared to analysts' expectations of $907.07 million. During the same quarter in the previous year, the company earned $3.02 EPS. The business's quarterly revenue was down .1% compared to the same quarter last year. As a group, equities research analysts predict that Crocs, Inc. will post 13.2 earnings per share for the current year.
Insider Buying and Selling at Crocs
In other Crocs news, EVP Shannon Sisler sold 4,659 shares of the business's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $109.75, for a total value of $511,325.25. Following the completion of the sale, the executive vice president now owns 29,299 shares in the company, valued at approximately $3,215,565.25. The trade was a 13.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ian Bickley sold 3,044 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $115.89, for a total transaction of $352,769.16. Following the completion of the transaction, the director now owns 27,505 shares in the company, valued at $3,187,554.45. This represents a 9.96% decrease in their position. The disclosure for this sale can be found here. Company insiders own 3.00% of the company's stock.
Crocs Company Profile
(
Free Report)
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
See Also

Before you consider Crocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.
While Crocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.